Schizophrenia News and Research

Latest Schizophrenia News and Research

Patients favor non-invasive neuromodulation for neurological and mental health disorders

A new study, led by experts at the University of Nottingham, has found that patients who need treatment for neurological and mental health disorders, would favour non-invasive neuromodulation interventions over current interventions such as pharmaceutical drugs.

27 Feb 2025

Understanding sex differences in the genetic basis of schizophrenia

A joint research study conducted by the UAB and the UB has analyzed the relation between the genetic risk of having schizophrenia and mild subclinical traits in people of the general population.

26 Feb 2025

Study reveals brain structure variability in schizophrenia

The symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the brain.

26 Feb 2025

New research shows why limits on working memory exist

Working memory is what allows humans to juggle different pieces of information in short-term scenarios, like making a mental grocery list and then going shopping or remembering and then dialing a phone number.

24 Feb 2025

Genetic mutation linked to schizophrenia in both humans and mice

A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with the same mutation, a rare finding of a direct genetic link to psychosis, report researchers at the University of Illinois Urbana-Champaign and colleagues in Massachusetts and Germany.

19 Feb 2025

New AI hub for healthcare and neuromodulation set to launch in Geneva

The University hospitals of Geneva (HUG), the Department of Health and Mobilities (DSM) of the Canton of Geneva and the Wyss Center for Bio and Neuro Engineering enter into a three-party agreement to create an artificial intelligence (AI) reference hub for healthcare and neuromodulation with its inauguration set for the second half of the year.

17 Feb 2025

Diabetes drugs may boost brain health but experts warn of risks

Researchers reviewed 374 studies to explore how GLP-1RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent results for mood disorders.

16 Feb 2025

Identifying key brain circuit opens doors for new psychosis treatments

Our study investigated the brain circuits involved in psychosis-a condition characterized by delusions, hallucinations, disorganized thinking and detachment from reality.

13 Feb 2025

Study identifies novel enhancers linked to neuropsychiatric disorders

Neuropsychiatric disorders are becoming increasingly prevalent. Given their complex and multifactorial pathogenesis, there is an urgent need for effective and targeted therapies that can improve patients' quality of life.

13 Feb 2025

New research advances understanding of Parkinson's disease stages

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics for each of the five clinical stages of the disease.

12 Feb 2025

Study uncovers a significant presence of manic symptoms in schizophrenia patients

In a notable Genomic Press research report, researchers at the Aristotle University of Thessaloniki have uncovered a significant presence of manic symptoms in patients with schizophrenia spectrum disorders (SSDs), offering valuable insights that could reshape treatment approaches.

11 Feb 2025

Cerebral cortex plays key role in memory and novelty detection

The cerebral cortex is the largest part of a mammal's brain, and by some measures the most important. In humans in particular, it's where most things happen-like perception, thinking, memory storage and decision-making.

10 Feb 2025

Rising cannabis use disorder cases contribute to growing schizophrenia diagnoses

The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10% after cannabis legalization in Ontario, according to new research.

5 Feb 2025

Experimental drug shows promise in restoring memory in Alzheimer's model

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease.

4 Feb 2025

Single dose IV iron shows promise in treating anemia during pregnancy

Anemia during pregnancy is a common occurrence and often due to iron deficiency. It is a global public health problem, affecting an estimated 37 percent of pregnant individuals, according to the World Health Organization.

31 Jan 2025

Study identifies contrast perception deficit in people with schizophrenia

Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers of the University of Barcelona have identified a deficit in contrast perception in people with schizophrenia.

28 Jan 2025

Study offers new insight into how nature and nurture shape aggression in males

Like humans, mice will compete over territory and mates, and show increased confidence in their fighting skills the more they win.

24 Jan 2025

New genomic insights could transform bipolar disorder treatment

Study published in Nature identifies nearly 300 genomic regions associated with bipolar disorder, and 36 key genes involved in the disease.

23 Jan 2025

Benefits and risks of popular weight-loss drugs revealed

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity.

20 Jan 2025

Researchers create an atlas of health associations for GLP-1 receptor agonists

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for gastrointestinal and musculoskeletal issues.

20 Jan 2025